Citation

Baird C, Mirza R, Sharkey JM, Teichman R, Longmire R, Harkins D, Llanos J, Abraham J, McCannon C, Heller J, Tinklepaugh C, Rice W. U. S. Army Med. Dep. J. 2016; (3-16): 75-84.

Affiliation

Environmental Medicine Division, US Army Public Health Center, Aberdeen Proving Ground, Maryland.

Copyright

(Copyright © 2016, United States Army Medical Department)

DOI

unavailable

PMID

27613213

Abstract

An October 14, 2014 article in The New York Times reported that the US Department of Defense (DoD) concealed, for nearly a decade, circumstances surrounding service members' exposure to chemical warfare agents (CWA) while deployed to Iraq in support of Operations Iraqi Freedom and New Dawn from March 13, 2003, to December 31, 2011, and alleged failure of the DoD to provide expedient and adequate medical care. This report prompted the DoD to devise a public health investigation, with the Army Public Health Center (Provisional) as the lead agency to identify, evaluate, document, and track CWA casualties of the Iraq war. Further, the DoD revisited and revised clinical guidelines and health policies concerning CWA exposure based on current evidence-based guidelines and best practices.

Language: en